All In Biotech

Free tool

FAERS Monitor: Kyxata

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219921 or its brand name (Kyxata, Carboplatin). Reports on generic versions are filed under their own applications.

Reports

130,077

Serious

124,012

95% of reports

Hospitalization

55,788

Death reported

20,461

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use8,814
  • neutropenia7,633
  • anaemia7,391
  • nausea7,205
  • febrile neutropenia6,742
  • diarrhoea6,425
  • malignant neoplasm progression6,347
  • disease progression6,172
  • thrombocytopenia6,085
  • dyspnoea5,535
  • vomiting5,279
  • pyrexia4,983
  • fatigue4,834
  • drug ineffective4,483
  • death4,378

Reports by year received

View as table
YearReports
20041,263
20051,451
20061,358
20071,482
20081,356
20091,645
20101,876
20112,493
20123,407
20132,798
20142,638
20153,759
20164,289
20175,629
20187,631
20197,570
20207,832
20219,234
202211,523
202312,551
202413,571
202514,133
202610,587

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,924,082 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal6,74218.217.798,629
malignant neoplasm progressionSignal6,34710.610.452,110
neutropeniaSignal7,6339.69.355,554
thrombocytopeniaSignal6,0859.29.042,542
disease progressionSignal6,1728.88.640,919
anaemiaSignal7,3916.56.333,210
pyrexiaSignal4,9832.32.33,863
vomiting5,2791.81.81,989
off label use8,8141.61.62,239
diarrhoea6,4251.61.61,539
dyspnoea5,5351.61.51,221
nausea7,2051.51.41,140
fatigue4,8341.01.00
death4,3780.80.8178
drug ineffective4,4830.50.51,771

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.